Role of endothelin and endothelin receptor antagonists in renal disease.
about
Avosentan reduces albumin excretion in diabetics with macroalbuminuriaDelayed graft function in the kidney transplantTubulointerstitial injury and the progression of chronic kidney diseaseInhibition of ENaC by endothelin-1Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.Endothelin receptors: what's new and what do we need to know?The lipid moiety of haemozoin (Malaria Pigment) and P. falciparum parasitised red blood cells bind synthetic and native endothelin-1Changes in renal medulla gene expression in a pre-clinical model of post cardiopulmonary bypass acute kidney injury.Potential renovascular hypertension, space missions, and the role of magnesium.Regulation of blood pressure and salt homeostasis by endothelin.Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in ratsControl of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2.State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension.Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosisEpidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndromeOat Protects against Diabetic Nephropathy in Rats via Attenuating Advanced Glycation End Products and Nuclear Factor Kappa B.Acute renal failure and hepatitis following ingestion of carp gallbladder.Role of endothelin receptor A and NADPH oxidase in vascular abnormalities.New approaches to the treatment of nephropathy in diabetes.Emerging drugs for managing kidney disease in patients with diabetes.The possible potential therapeutic targets for drug induced gingival overgrowth.Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.Cardiorenal syndrome: new developments in the understanding and pharmacologic management.Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.Future strategies to prevent renal microvascular disease complications in diabetes.Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin.Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects.Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm.Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation.Endothelin-1 and its receptors ET(A) and ET(B) in drug-induced gingival overgrowth.Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue.
P2860
Q24642372-604E3094-753E-4C23-BD65-4A8F3113C317Q26824506-826FCB40-F026-4A64-88CA-0B0C905C93D0Q26852862-680939F1-3948-43E6-A6D0-C5E30831B095Q27005957-E1600B9C-6405-41E7-8177-B4F09D3F2B96Q33339723-333BCA31-4147-433E-849E-E31665A504C1Q33686555-0AE92101-C487-444D-B31E-EFF6D0C76CCAQ33692573-4166EF35-1565-476B-9FF5-4B69AE563691Q34409986-E5C5F8FD-98F5-48E9-8E41-66A0A616CDE6Q35026662-F92B6924-9A4E-4256-9B96-173324C166F3Q35609851-7F2E50BA-F3E9-42FF-84BC-CB73D096A9A4Q36646387-93F59A90-D7EA-4E60-9EE9-4C78AA213EFFQ36850156-E08E54E4-58AD-4AC8-BE7B-EFB03BC884DDQ37078824-D99CCD93-004B-4E7A-836E-8381EFE91130Q37174006-73E11CDB-FEC1-4490-8A1D-69F993731E6BQ37195386-E2FA3456-091A-4664-80D3-C143242F9079Q37261237-E5117F40-801B-4BCD-9742-BDF850A75722Q37400060-89A041AF-B04F-4275-8A9D-20417C3FF13FQ37790995-2734765E-1FB1-43DD-AA29-E2193E3CF488Q37899907-F5F61CA8-793E-4336-BCA6-46D53BF3FA01Q38075029-49E8ED7E-28F5-4EE5-831B-08E399E576B1Q38108291-197E1DC1-E0C7-4535-ABB8-A6F1BAF388CBQ38117232-E0C190CA-0430-462E-9870-AC501ECF383DQ38127668-0963F17D-2046-4DCE-9610-A152FD454096Q39107039-3584E05A-7A78-418A-B8FB-B52F6AB2AA78Q39879255-653D4090-FE79-48F3-AC0F-EFFE461B1ECCQ40139541-A0568B37-18E2-4524-82EB-35AD53629FEBQ41855773-05BA1B44-CFF0-4A93-8026-7D39DBE51964Q45978253-FDF73435-BC46-4B55-A77F-9E7D88B08660Q46091583-F5C4CF80-058F-4C01-899E-B63008DE0BD7Q46738367-B27965D2-8539-4626-BD61-236950A48A07Q47107722-30D0424E-B2AF-4D05-A859-A18B7935F0B2Q54558416-F66A2396-34DD-4B42-95B6-B3568E69D557Q54617446-2ADAE0E1-8EAA-45AB-95C6-7A4B05FA9011
P2860
Role of endothelin and endothelin receptor antagonists in renal disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of endothelin and endothelin receptor antagonists in renal disease.
@ast
Role of endothelin and endothelin receptor antagonists in renal disease.
@en
type
label
Role of endothelin and endothelin receptor antagonists in renal disease.
@ast
Role of endothelin and endothelin receptor antagonists in renal disease.
@en
prefLabel
Role of endothelin and endothelin receptor antagonists in renal disease.
@ast
Role of endothelin and endothelin receptor antagonists in renal disease.
@en
P2860
P1476
Role of endothelin and endothelin receptor antagonists in renal disease.
@en
P2093
P2860
P356
10.1111/J.1365-2362.2006.01689.X
P478
36 Suppl 3
P577
2006-09-01T00:00:00Z